Relmada Therapeutics Inc (RLMD)

Finanzdaten der Relmada Therapeutics Inc-Aktie (RLMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	22.87%15.01	19.46	20.33	10.33	10.22
Research and Development	3.78%8.39	8.09	8.07	4.04	2.82
Operating Income/Loss	22.87%-15.01	-19.46	-20.33	-10.33	-10.22
Nonoperating Income/Loss	411.68%2.10	0.41	0.47	0.24	0.35
	32.22%-12.91	-19.05	-19.87	-10.09	-9.87
Attributable To Parent	32.22%-12.91	-19.05	-19.87	-10.09	-9.87
Basic Average Shares	29.77%112.38	86.60	-	33.19	33.19
Diluted Average Shares	29.77%112.38	86.60	-	33.19	33.19
Basic Earnings Per Share	50.00%-0.11	-0.22	-	-0.30	-0.30
Diluted Earnings Per Share	50.00%-0.11	-0.22	-	-0.30	-0.30